Brief: Gensight's LUMEVOQ, GS030 Data To Be Presented At 2021 ISGEDR

Gensight Biologics SA

01/09/2021 16:58

Sept 1 (Reuters) - GENSIGHT BIOLOGICS SA  SIGHT.PA :
    * CLINICAL DATA ON GENSIGHT BIOLOGICS' LUMEVOQ AND GS030
GENE
THERAPIES TO BE PRESENTED AT 2021 ISGEDR AND SEVERAL INVESTOR
AND INDUSTRY MEETINGS IN SEPTEMBER

Source text for Eikon:  ID:nBwJ0qlPa 
Further company coverage:  SIGHT.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587 696 600;))